Address: GPO Box 9848, Canberra ACT 2601,Australia
Tel: 602 6289 1555
Web: http://www.health.gov.au/
The Department of Health was established in 1921 and as since undergone a number of changes in its name function and structure.
The first change was in 1987 when the Department of Health was merged with the Department of Community Services to form the Department of Community Services and Health.
The Department of Health, Housing and Community Services was then formed in June 1991, reflecting the transfer of housing industry programs from the Department of Industry, Technology and Commerce to the Department of Community Services and Health.
In March 1993 the Department of Local Government joined with the Department of Health, Housing and Community Services to form the Department of Health, Housing, Local Government and Community Services. Subsequently in 1994 the Department’s name was changed to the Department of Human Services and Health.
When a new government was elected in March 1996, the Department’s name changed to the Department of Health and Family Services. At this time, it gained responsibility for the Supported Accommodation Assistance Program from the former Department of Housing and Regional Development.
The Department later assumed responsibility for Aboriginal and Torres Strait Islander health matters from the Aboriginal and Torres Strait Islander Commission.
After the October 1998 election, the Department’s name changed to the Department of Health and Aged Care to reflect its new responsibilities and functions. Responsibility for Family and Children’s Services, Disability Programs and the Commonwealth Rehabilitation Service were transferred to the Department of Family and Community Services on 22 October 1998.
Following the November 2001 election, Department of Health and Aged Care changed its name to the Department of Health and Ageing. The portfolio also gained the Commonwealth Rehabilitation Service from the Department of Family and Community Services.
Regulatory
New Government health priorities and policies, highlighting those concerning preventive health. The Rudd Labor Government’s goal in health is to create a modern health system designed for the health needs…
Richard Day of the University of New South Wales, writing in the October 2023 edition of DIA’s Global Forum magazine, looks at updates to the health technology assessment (HTA) processes…
Shawview Consulting’s Brendan Shaw looks back on a sombre United Nations High Level Meeting on Universal Health Coverage in New York last month, as stakeholders reflected on the long road…
After last year’s acquisition of Vifor Pharma, the firm’s largest ever, opened new avenues for diversification, the ground-breaking approval of the Hemgenix gene therapy for Hemophilia B was an equally…
Shawview Consulting’s Brendan Shaw casts his eye over the increased industry focus on Environment, Social, and Governance (ESG) issues in recent years, urging pharma companies to deliver on their ESG promises…
Brendan Shaw looks ahead to the rest of 2023, identifying five key trends to watch out for in the healthcare and life sciences sector. With the worst of COVID-19 now…
CSL, Australia’s largest biopharma company, overcame the challenges of the pandemic-related decline in plasma collection and has since racked up wins such as the acquisition of Vifor, the largest in…
A roundup of some of the latest news from Australian pharma, including CSL’s unification of business units, a workers strike at Pfizer’s manufacturing plant, a new USD 173 million research…
Pharmaceutical policy issues played a major role in Australia’s recent national election. Shawview Consulting’s Brendan Shaw outlines the medicines issues that came under scrutiny during the campaign. It was the…
Writing in April edition of DIA’s Global Forum magazine, the University of New South Wales’s Richard Day looks at Australia’s National Medicines Policy (NMP) and how it is being reshaped…
Writing in the January edition of DIA’s Global Forum magazine, Julia Chan, David Liew, Jana Stojanova, and Chris McMaster of Austin Health, Melbourne and St. Vincent’s Hospital Sydney outline how…
In conversation in the November issue of DIA’s Global Forum magazine, Australian Pharmaceutical medical and scientific Professionals Association (APPA) Past President David Grolman highlights the contributions that Australia is already…
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully managed to avoid the worst of the COVID-19 pandemic, providing opportunities for the life…
See our Cookie Privacy Policy Here
